ArticleAmerican heart journal2022

Fibroblast growth factor-23 and subclinical markers of cardiac dysfunction: The coronary artery risk development in young adults (CARDIA) study.

Ehimare Akhabue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.